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Abstract 
Low molecular weight gelators (LMWGs) have gained much attention over the last few decades, 
because of their ability to form supramolecular architectures as well as their many potential 
applications in biomedical research and as advanced materials. Most of the gelators were 
discovered through serendipity, and their structural requirements are somewhat ambiguous. This 
is due, in part, to the fact that the supramolecular gelation phenomenon is not yet fully 
understood, though many structural classes have been found to be excellent organogelators. 
Carbohydrates are abundant natural resources that are useful in preparing advanced materials. 
We have previously showed that monosaccharide derivatives can form effective low molecular 
weight gelators for both organic solvents and aqueous mixtures. In this research, we have studied 
the gelation capability of several glucosamine derivatives. Several series of 4,6-O-acetal 
protected glucosamine derivatives were synthesized and screened for their gelation properties in 
several solvents. 
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1 
Introduction 
The exact definition of a gel can be somewhat ambiguous.  The word “gel” comes from Latin 
word “gelatus”, which means to immobilize or to freeze.  In general, a gel consists of two 
components: gelator molecules and solvent molecules; thus, a gel can be defined as a semisolid 
material in which a large amount of solvent molecules are entrapped within the three 
dimensional network formed by gelator molecules.1-6 Several products that are used routinely in 
our everyday lives are comprised, at least in part, by gels; examples include contact lenses, 
shaving cream, shoe padding, etc. Gels have also shown many potential applications in 
biochemical fields, such as tissue engineering, drug delivery, and separation of RNA and 
DNA.3,7 Most of the gels that we use in our routine life are polymer gels, in which covalent or 
chemical bonds are involved in the formation of the gel; hence, polymer gels are also known as 
chemical gels.2-4  Polyvinyl alcohol 1 and polyethylene glycol 2 in Figure 1 are examples of 
polymers that form gels in water.  
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Figure 1.  Structures of two polymer hydrogels, polyvinyl alcohol 1 and polyethylene glycol 2.  
 
One major advantage of polymer gels is that they have good mechanical strength, but the gels are 
not degradable and typically require high concentrations of the polymer.4 Several polymer gels 
have been used in various biochemical applications, such as tissue engineering; for example, 
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hyaluronate (Figure 2) is a naturally-occurring hydrogelator that has been used for growing 
artificial skin and intradermal implants, as well as for wound healing. 3 
 
O
HO
O
NH
HO
O
O
HO
OH
HOOC
O
H H
H
H
H
H
H
H
H
H
3  
Figure 2. Structure of hyaluronate, which has shown potential applications in tissue engineering.  
 
Usually, gels are formed by dissolving the gelator in the solvent (water or organic solvent), using 
heat to help the compound dissolve, and then allowing the solution to cool.  The temperature at 
which this solution forms a gel is known as the Tgel (temperature of gelation).
8 Advantages of 
LMWGs include their ability to be synthesized from readily available, cheap starting materials, 
the ease of such syntheses compared to the syntheses of polymer gels, and that their formation is 
typically thermally reversible.  Of particular significance is thermal reversibility, meaning that 
upon heating the gel, the gel goes back into solution (the temperature at which the gelator goes 
into the solution is known as the Tsol temperature of solvation).
 8, 9 
 
Gels formed by LMWGs are called physical or supramolecular gels, because of the fact that the 
formation of their three-dimensional networks occurs through non-covalent interactions, such as 
hydrogen bonding, hydrophobic interactions, π-π stacking, dipole-dipole interactions, and Van 
der Waals interactions. 8-12 Depending on the solvent in which they form a gel, LMWGS can be 
 
 
3 
divide into two types: hydrogelators (LMHGs) and organogelators (LMOGs). Different types of 
intermolecular interactions are important for LMHGs and LMOGs; hydrogelators depend mainly 
on hydrophobic interactions rather than hydrogen bonding for gel formation, while 
organogelators are primarily dependent on hydrogen bonding interactions.10-12  
 
Low molecular weight gelators have found many applications in sensors, 
electrophotonics/photonics, cosmetics, hydrometallurgy, lubrications, structure directing agents 
(templates), conservation of art, etc.13-20  Because the main driving force for supramolecular 
hydrogel is  hydrophobic interactions, the structure of hydrogelators mainly consists of 
contrasting polar and nonpolar regions, in which polar groups mainly include amino acids or 
sugars,20-29 while the nonpolar regions mainly include long alkyl chains or aromatic rings.30-32  
Figure 3 shows the structures of several compounds (4-8) that can form gels in water. 
Compounds 6 and 7 are ambidextrous (they are able to gelate both water and organic solvents).33 
Compound 8 has a unique bisoxalyl group with a phenyl side chain; it forms gels in organic 
solvents, and it was found that the trans isomer can also form a gel in water. 34 
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Figure 3. Structures of some hydrogelators.32-34 
 
 
Many studies have been directed towards designing hydrogelators.  Most of them are discovered 
serendipitously, and improved analogs are found by modifying the parent structure.  To design a 
hydrogel, there must be a balance between the polar and nonpolar groups.  Furhop and 
coworkers synthesized a library of LMHGs by introducing the alkyl amine chain into several 
aldonic acids.33 Hamilton’s group has shown that ureas with short alkyl chains act as 
hydrogelators, while those with larger chains act as organogelators.25 Urea derivatives are placed 
in a separate category, because they exhibit strong hydrogen bonding, even in water.25  Suzuki 
and their group synthesized many compounds with positively charged nitrogen atom into the 
structure and tested for their gelation activity, many of them form a good  gel in pure water.28  
Figure 4 shows several hydrogelators that can form a gel at low concentrations (up to 
1mg/mL).28   
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Figure 4. Structure of series of hydrogelators. 28  
 
The main attractive forces responsible for gel formation in organic solvents are hydrogen 
bonding, dipole-dipole interactions, and metal coordination. Weiss and Lin35-37 employed a 
molecular engineering approach in their design of organogelators by investigating the influence 
of changing three structural components: aromatic groups, linkers, and steroids; 
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 Figure 5.  ALS Gelators35-37 
 
They found that the shape of the molecules is vital, compound in figure 5 are more efficient 
gelator with their β anomers compared to their α anomers.38 There are several organogelators are 
shown in Figure 6.  Compound 9 form a gel in various organic solvents such as alcohols, nitriles, 
 
 
6 
amines and alkanes but addition of alkoxy group at 2 and 3 positions loose their gelation activity 
Compound 11 form a lyotropic gels41 While compound 13  can form gel in various polar  organic 
solvents such as DMSO, DMF, 1,2 dichloroethane and nitrobenzene but replacing alkyl chain 
with shorter chain length reduces gelation efficiency.42 LMOGs have been used in many 
industrial applications, such as lubrications and cosmetics, for a very long time.  Currently, they 
have also shown many potential applications as sensors, electrophotonics/photonics, 
hydrometallurgic compounds, structure directing agents (templates), art conservation agents, 
etc.13-20 
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Figure 6. Structure of various LMOGs.39-42 
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 Consideration of raw material is always necessary when designing a synthesis of drug molecule. 
It should be available readily with low cost. Various carbohydrate derivatives are naturally 
available and also some of them found in human body. They are biocompatible, and have no 
harmful effect if inserted into the human body.  They also possess multiple free hydroxyl groups, 
which can aid in solubility, and be harnessed for their ability to form hydrogen bonds; the 
inherent chirality of these hydroxyl groups can also be used to direct the hydrogen bonds.  There 
are a number of gelators that are derived from sugars; for example, Wang and coworkers43-47 
have synthesized many sugar based gelators that behave as hydrogelators as well as 
organogelators.  Hydrogel formed by the sugars can be used in some biochemical applications.  
 
Many drugs have some toxicity issues that can be reduced by reducing the concentration of the 
drug, but reducing the dose of drug also reduces the activity. This problem can be overcome by 
increasing the local concentration of drug at the target site.  This can potentially be achieved by 
converting the drug into a prodrug analogue that is a hydrogelator.  Bing Xu and their group has 
shown that by functionalizing Vancomycin with a pyrene group, hydrogelation can occur and it 
can be useful in sustained drug delivery.46  While Tiller has shown that addition of pyrene 
moiety to Vancomycin leads to hydrogel formation, which can then be tethered on the cell 
surface, increasing the local concentration of the drug at the target site.47  However, one must 
pay attention to the toxicity issues arising from the build up of undesirable byproducts formed by 
the degradation of the gelator molecules.  Because sugars are ubiquitous in living organisms, the 
degradation products of the sugar based hydro gels are likely to be biocompatible.  Figure 7 
shows some sugar-based hydrogelators. 
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Figure 7. Several sugar-based hydrogelators. 48-51 
 
George John and his group have synthesized several amygdaline derivatives by incorporating 
long chain fatty acids to their structure.  These compounds were tested for their gelation activity, 
and all of the derivatives showed good gelation activity in polar and nonpolar solvents.  The gels 
were then tested for their proclivity for degradation in the presence of hydrolase and lipolase 
enzymes; it was found that degradation of the gel occurred by the cleavage of the ester bonds by 
the hydrolase enzyme, and that the long chain fatty acids were necessary for gelation.  Shinkai 
and Hung have shown that compound 14 can form a gel in different organic solvents through 
intermolecular hydrogen bonding, and that the compound can also gel water through π-π 
stacking.48 Shimizi’s group has reported several aldopyranoside based amphiphilic gelators. This 
compound mostly forms a gel in organic solvents, but can also form a gel in water in presence of 
small amount of methanol or ethanol, which was necessary for solvation.49-52  
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Our research: 
Our group has discovered several novel classes of organogelators and hydrogelators derived 
from common monosaccharides.  We previously synthesized several aliphatic and aromatic ester 
derivatives of 4,6-O-benzylidene-methyl-α-D-glucopyranoside, and found that the compounds 
with short, terminal acetylene containing side chains (compounds 20, 21, and 22) were good 
gelators.  We also prepared some long chain (18-22 carbon) alkynyl esters derivatives that can 
gelate ethanol/water mixtures, and we found that the terminal alkynyl group is essential for the 
gelation activity.43 
O
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O
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HO
OCH3
O
O
O
n
n=0
n=1
n=2
20-22
 
 
     Figure 8. Sugar derived low molecular weight gelators.  
 
In addition, our group has also synthesized several N-linked carbamates (in which the nitrogen 
atom is attached to the sugar head group) and O-linked carbamates (in which the oxygen atom is 
attached to the sugar head group) derivatives of the previous 4,6-O-benzylidene-methyl-α-D-
glucopyranoside esters, and we have found that, unlike the ester derivatives, it is not necessary to 
have a terminal alkynyl group for good gelation activity.  Compounds with the saturated alkyl 
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group and cyclohexyl group proved to be very good gelators.45 The N-linked carbamate 
compounds 24 can form gels at concentrations as low as 1.7 mg/mL in DMSO:H2O (1:2), while 
in EtOH:H2O it can form gels at concentrations as low as 2.2 mg/mL.  O-linked carbamate 
compounds 25 formed gels at concentrations as low as 1 mg/mL, in both DMSO:H2O and EtOH: 
H2O. 45  
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Figure 9.  O-Linked and N-linked carbamates derivatives. 45 
  
We are interested in synthesizing and characterizing other sugar derivatives in order to better 
understand their self assembling behavior in different solvents, and to determine the role of the 
head group in gel formation.  Thus, we synthesized other head groups derived from sugar 
molecules, made some ester and amide derivatives, and analyzed them for their gelation activity.  
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Results and Discussions: 
 
1. Synthesis and characterization of 4,6-O-isopropylidene acetal derivatives 
 
The preparation of the 4,6-O-isopropylidene-protected headgroup 28 is shown in Scheme 1. 
Compound 28 was synthesized from methyl-α-D-glucopyrinoside 27 by treating it with 2,2 
dimethoxy propane in the presence of a catalytic amount of p-toluenesulphonic acid in 
anhydrous dimethylformamide (DMF). The reaction was run for 16 hrs at 70oC. Product was 
purified by flash chromatography using Hexane: ethyl acetate as a solvent and gives 84% yield. 
   
O
O
HO
OCH3
OH
Op-TsOH
DMF  600C
84%
+ OMeMeOOHO
HO
OCH3
OH
HO
27 28  
Scheme 1. Synthesis of 4,6-O isopropylidene acetal head group. 
 
Once compound 28 was obtained, several esterification reactions using the corresponding acid 
chlorides were carried out to afford the 2,3-diesters 29-32A, 2-esters 29-32B, and 3-esters 29-
32C (Scheme 2). Generally compounds A and B were the major products; when the acyl group is 
less bulky, the 3-ester derivatives C were obtained in small quantities. 
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Scheme 2. Synthesis of isopropylidene ester derivatives.  
 
 
The products were purified by flash chromatography using fine silica gel and hexane: ethyl 
acetate as the eluent. Once the compounds were purified and dried thoroughly under vacuum, 
their gelation properties were evaluated in several different solvents: hexane, ethanol, water, 
ethanol:water 1:2, and DMSO:water 1:2.  To test the gelation, 2-4 mg of compound and 0.1mL 
of solvent were transferred into the testing vials and heated and sonicated until the compound 
was fully dissolved.  The resulting solution was allowed to sit undisturbed for 20 minutes while 
it cooled back to room temperature. The compound was observed to see if precipitation, 
recrystallization, or gelation had occurred (or if the compound had remained solvated).  If the 
compound had appeared to gelate (the mixture was homogenous and its viscosity had greatly 
increased), the sample vial was inverted; if the mixture didn’t flow and stuck to the bottom of the 
vial, it was denoted as a stable gel, while unstable gels were denoted as mixtures in which some 
flow or escape of solvent from the matrix was observed.  Compounds which formed a stable gel 
were further diluted by 0.1 mL of solvent to determine the minimum gelation concentration.  
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Table 1 shows the gel testing results of the various 2-ester derivatives (29-32B). Table 2 shows 
the gel testing results of various dimer derivatives (29-32A). Most of the isopropylidene ester 
derivatives were insoluble in hexane and water, and soluble in the remaining solvents.  
 
B
O
O
HO
OCH3
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R
O
R =
29B 30B 31B
32B
 
 
Table 1. Gelation Test results for 2-esters derivatives of 4,6-O isopropylidene derivatives. 
Positive gelation results are listed in mg/mL. * Unstable gel. I – insoluble, P – precipitate, S – 
soluble at 20 mg/mL 
 
Compound  
Number 
R =  Hexane Ethanol Water DMSO:H2O 
(1:2) 
EtoH:H2O 
(1:2) 
29B  
I S I S S 
30B 
 
I S I S S 
31B 
 
I S I S S 
32B  
I S I S S 
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Table: 2 Gelation test results for dimers of 4,6-O-isopropylidine acetal. Positive gelation results 
are listed in mg/mL. * Unstable gel. I – insoluble, P – precipitate, S – soluble at 20 mg/mL 
 
Compound  
Number 
R= Hexane Ethanol Water DMSO:H2O 
(1:2) 
EtoH:H2O 
(1:2) 
29A  
I S I S S 
30A 
 
I S I S S 
31A 
 
I S I S S 
32A  
I S I S S 
 
 
2.  D-glucosamine derivatives 
 
As we have seen, the ester derivatives of 4,6-O benzylidene-methyl-α-D-glucopyranoside with a 
free hydroxyl group at the 3-position form good gels in water and organic solvents, while the 
diester derivatives were less effective gelators.43  In addition, isolation of the dimer and 
monoesters from one another proved to be challenging in some instances.  D-glucosamine is 
another naturally occurring sugar found in many plants as well as in the human body. For 
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example, chitosan is the N-deacetylated product of chitin, and has found many applications in 
tissue engineering due to its biocompatibility and low toxicity.3 Methyl pyrrolidinone derivatives 
have shown some positive effect on bone formation.3 Hyaluronate is another glucosamine-based 
natural hydrogelators; several hydrazine derivatives of hyalluronate have been shown to form a 
hydrogel by covalent cross-linking.3 Hydrogels formed by hyalluronate derivatives can be 
degraded in the presence of enzymes present in serum; as a result, there are potential applications 
for drug delivery, as well as in tissue engineering.3 
  
From a synthetic view point, the amino group is more reactive than a hydroxyl group, and better 
regioselectivity should be exhibited, leading to easier separation and better yields.  In addition, 
the formation of an amide may lead to increased gelation activity, as the hydrogen bonding of 
amides is stronger than esters, which might be helpful in the gelation mechanism; our previous 
research in this area has shown that the amides form better gels than the esters.  
 
2.1. Preparation of cationic amide derivatives  
Our group has already synthesized several amides with the 4,6-O benzylidene acetal as the head 
group, and we have shown that most of the amides are good gelators in aqueous mixtures of 
ethanol and water or DMSO and water, but few of the amides form gels in pure water.  We are 
interested in forming hydrogels, so we introduced a benzyl amine group or an imidazole group 
into the compounds in an effort to improve the solubility of the compounds in water.  As shown 
in Scheme 3, synthesis of the product was carried out by treating compound 33 with one 
equivalent of bromo acetyl bromide in presence of 2 equivalents of potassium carbonate for six 
hours.  The product was purified by flash chromatography using a solvent gradient of 
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Hexane:DCM:MeOH as the eluent. The resulting product 34 was then reacted with 2 equivalents 
of benzyl amine, pyridine, or imidazole in DMF at 60oC for 12 hrs to form compounds 35, 36, 37, 
respectively.  These compounds were analyzed for their gelation activity, and the results are 
shown in Table 3.  
 
O
O
HO
NH2
O
OMe
O
O
HO
NH
O
OMe
O
Br
K2CO3, Bromoacetyl bromide
THF, 0
o
C
33
34
O
O
HO
NH
O
OMe
O
HN
35
O
O
HO
NH
O
OMe
O
N Br
36
O
O
HO
NH
O
OMe
O
N
N
37
 
Scheme 3. Synthesis of amino-acetyl amide derivatives of 34.  
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Table: 3 Gelation Test results for compounds 35-37. Positive gelation results are listed in 
mg/mL.  Legend: *-Unstable gel, I – insoluble, P – precipitate, S – soluble at 20 mg/mL 
 
 
O
O
HO
NH
O
OMe
O
R  
Compound  
Number 
R= Hexane Ethanol Water DMSO:H2O 
(1:2) 
EtoH:H2O 
(1:2) 
35 
HN
 
I S I 6.0 
 
5.7 
 
36 
N
 
I S 10 5.0 5.0 
37 
N
N
 
I S I 7.0 
 
7.0 
 
 
 
 
Besides benzylidene acetal, we also prepared the derivatives with isopropylidene acetal for 
comparison purposes. These are shown in Schemes 4; the synthesis of 42 followed similar 
methods to those for the preparation of acetal 34, using dimethoxypropane as the reagent instead 
of benzylidene dimethyl acetal.45 Once product 42 was synthesized, it was reacted with 2 
equivalents of benzyl amine, imidazole, or pyridine to afford compounds 43, 44, and 45.  
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Scheme 4.  Synthesis of isopropylidene protected glucosamine 42. 
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Scheme 5.  Synthesis of isopropylidene protected heterocyclic derivatives of glucosamine.  
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The gelation test results are shown in Table 4. Compared to the benzylidene acetal derivatives 
35-37, compounds 43-45 are not effective gelators in the solvents tested.  This indicated that the 
4,6-benzylidene acetal protective group is important for gelation.  To further test the tolerance of 
the acetal group, we then prepared p-methoxy benzylidene acetal derivatives as shown in the 
next section.  
 
Table 4: Gelation test results for amide derivatives of 4,6-O-isopropylidine acetal derivatives. 
Positive gelation results are listed in mg/mL. Legend: *-unstable gel, I – insoluble, P – 
precipitate, S – soluble at 20 mg/mL. 
 
OO
HO
NH
O
OMe
O
R  
Compound 
number 
R= Hexane Ethanol Water DMSO:H2O 
(1:2) 
Ethanol:H2O 
(1:2) 
43 
HN
 
I S I S S 
44 
N
 
I S S S S 
45 
N
N
 
I S S S S 
 
 
 
20 
2.2. Synthesis of 4,6-O- p-methoxybenzylidene protected glucosamine derivatives 
Synthesis of the p-methoxybenzylidene head group was relatively straight forward, as it was 
analogous to the synthesis of the benzylidene protected compound 40 (Scheme 5).  In the first 
step, the anomeric hydroxyl group of N-acetyl-D-glucosamine was converted to a methoxy group 
by refluxing the compound in methanol in the presence of Amberlite IR-120 resin.  After 
removal of the methanol and drying under vacuum, the resulting product was dissolved in 
anhydrous DMF, and reacted with compound 47 for 16 hrs in the presence of p-toluenesulfonic 
acid to give compound 48. Deprotection of acetyl group was carried out with potassium 
hydroxide in ethanol for 16 hrs at reflux, and after workup, purification was conducted by 
column chromatography to give compound 49.  
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Scheme 6. Synthesis of 4,6-O-p-methoxy benzylidine acetal head group.  
 
Compound 49 was used to furnish a variety of amide derivatives, 48-56, as shown in Scheme 6 
(compound 48 is the synthetic precursor to 49).  Compound 49 was dissolved in anhydrous 
dichloromethane, along with a catalytic amount of pyridine or potassium carbonate, and the 
reaction mixture was cooled to 0o C.  The corresponding acid chloride was added drop wise to 
the reaction, which was warmed to room temperature and allowed to stir for 8-10 hrs.  
Purification of the crude product by flash chromatography gave desired the amide derivatives 50-
56.  Gel testing of the compounds was conducted and the results are shown in Table 5. 
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Scheme 7. Synthesis of amide derivatives of p-methoxy benzylidene acetal head group. 
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Scheme 8. Synthesis of p-methoxybenzylidene protected heterocyclic derivatives of glucosamine.  
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Compound 54 reacted with 2 equivalents of pyridine, benzyl amine or imidazole in DMF at 60oC. 
to give compound 57, 58,  and 59 respectively, and tested for their gelation activity in hexane, 
ethanol, water, ethanol: water 1:2 and DMSO:water 1:2. The results of the gel testing are shown 
in Table 5. 
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Figure 10. Structures of synthesized amide derivatives. 
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Table 5: Gelation test results for amide derivatives of 49. Positive gelation results are listed in 
mg/mL. Legend: *-Unstable gel, I – insoluble, P – precipitate, S – soluble at 20 mg/mL 
 
 Structures of R  Hexane Ethanol Water DMSO:H2O 
(1:2) 
EtoH:H2O 
(1:2) 
48 
  CH3   
I S 10 
 
7.4 8.0 
50 
 
I 20 
 
I 5.4 6.0 
 
51 
 
I 20 
 
I 5.7 
 
5.7 
 
52 
 
I 10 
 
I 4.6  
 
8 
 
53 
 
I 8.0 
 
I 5.7 
 
10 
 
54 Br
 
I S I S P 
55 
 
I 20 * I 5 
 
8.8 
 
56 
 
I S I 6.0 7.4 
57 
N
Br
 
I S S S S 
58 
N
H  
I 8.0 
 
7.4 
 
5.4 
 
3.0 
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Table 5 shows that most of the compounds form gels in aqueous ethanol and aqueous DMSO, 
except for compounds 54 and 57.  As with the previous amide series, we have discovered that the 
terminal alkynyl group is not necessary for good gelation activity (compounds 50 and 55).  
Compounds 48 and 58 were able to form gels in water, at concentrations as low as 10 mg/mL 
and 7.4 mg/mL, respectively; compound 58 also formed a gel in aqueous ethanol at 
concentrations as low as 3.0 mg/mL.   It is believed that the nitrogen of the benzyl amine moiety 
in compound 58 can form an additional hydrogen bond with the methoxy group of the p-
methoxybenzylidene acetal, or that additional π-π stacking interactions between the two phenyl 
groups are the cause of the improved gelation. 
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Figure 11. Photographs of several gels: 1) A gel formed by compound 50 at 6.0 mg/mL in 
EtOH:H2O (1:2). 2) A gel formed by compound 58 in H2O at 7.4 mg/mL. 3) A gel formed by 
compound 55 at 8.8 mg/mL in EtOH:H2O (1:2). 4) A gel formed by compound 58 in 
DMSO:H2O  (1:2) at 5.4 mg/mL.  
 
 
 
 
 
 
 
 
 
 
27 
Conclusions: 
 A series of amides were synthesized using D-glucosamine derivatives as the headgroups. The 
headgroups include D-glucosamine protected with 4,6-isopropylidene acetal, benzylidene acetal, 
and p-methoxybenzylidene acetal. The amine in the headgroups was easily functionalized with 
acid chloride to yield the amide derivatives. Compounds with isopropylidene acetal protective 
groups did not show gelation activity while compounds with benzylidene and p-methoxy 
benzylidene acetal are good gelators in several solvents. The amino group at the 2 position 
increases the gelation activity by hydrogen bonding. Free hydroxyl group at the 3 position can 
act as a hydrogen bond door and form a hydrogen bond. These small molecules can be useful for 
entrapping large biomoelcules such as enzymes and provide a good media for enzymatic 
reactions. 
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Experimental section: 
 Gelation Testing:  
The compounds were tested in a vial with a rubber lined screw cap. started with 20 mg/mL 
concentration (2mg in 0.1mL). The mixture of Solvent and compound was heated and sonicated. 
The solution was allowed to cool for 15-20 minutes. If a stable gel formed, 0.1 mL of the same 
solvent was added and the heating/sonication and cooling was repeated. The process was 
repeated until the gelation concentration and the concentration prior to the unstable gel was 
recorded as the Minimum Gelation Concentration (MGC).45 
 
Synthesis of compound 28 
The crude product was purified by flash chromatography by Hexane: EtOAc with 76% yield.  1H 
NMR (400 MHz, CDCl3) δ 4.76 (d, J = 4.0, 1H), 3.87 (dd, J = 10.5, 5.2, 1H), 3.82 – 3.70 (m, 
2H), 3.67 – 3.49 (m, 3H), 3.48 – 3.39 (m, 3H), 2.65 (s, 1H), 2.23 (d, J = 9.7, 1H), 1.50 (d, J = 
10.9, 3H), 1.42 (d, J = 12.4, 3H). 13C NMR (100 MHz, CDCl3) δ 101.9, 99.7, 80.8, 72.8, 71.7, 
68.9, 62.3, 55.5, 23.4. 
 
Synthesis of benzyl ester 30a 
The crude product was purified by flash chromatography using Hexane: EtOAc with 30% yield.  
1H NMR (400 MHz, CDCl3) δ 8.17 (d, J = 7.5, 9H), 7.97 (d, J = 7.4, 3H), 7.68 (t, J = 7.5, 5H), 
7.58 – 7.42 (m, 12H), 7.37 (t, J = 7.1, 4H), 5.95 – 5.80 (m, 2H), 5.24 – 5.07 (m, 3H), 3.91 (ddd, J 
= 21.2, 16.2, 8.6, 5H), 3.40 (s, 3H), 1.44 (d, J = 45.5, 7H). 13C NMR (100 MHz, CDCl3) δ 169.9, 
133.4, 135.9, 130.9, 109.8, 102.1, 82.3, 75.1, 73.2, 68.5, 62.5, 53.5, 22.6. 
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Synthesis of 2-benzyl ester 30b 
The crude product was purified by flash chromatography using Hexane: EtOAc with 30% yield. 
1H NMR (400 MHz, CDCl3) δ 8.17 – 8.03 (m, 2H), 7.59 (t, J = 7.4, 1H), 7.52 – 7.41 (m, 2H), 
5.01 (dt, J = 9.5, 3.8, 3H), 4.20 (t, J = 8.9, 1H), 3.91 (dd, J = 10.2, 4.7, 1H), 3.84 – 3.63 (m, 4H), 
3.37 (s, 3H), 2.35 (s, 1H), 1.54 (s, 16H), 1.46 (s, 4H). 13C NMR (CDCl3, 100MHz) δ 174.9, 
133.4, 129.9, 127.9, 103.8, 101.1, 76.3, 71.1, 69.0, 62.5, 55.5, 26.5. 
 
Synthesis of napthoyl dimer compound 31a 
 The pure product was purified by flash chromatography using Hexane: EtOAc with 26% yield. 
1H NMR (400 MHz, CDCl3) δ 8.92 (t, J = 13.6, 1H), 8.73 – 8.63 (m, 1H), 8.39 – 8.24 (m, 1H), 
8.08 – 7.76 (m, 6H), 7.67 – 7.30 (m, 8H), 6.05 (t, J = 9.6, 1H), 5.34 (dt, J = 13.6, 6.8, 1H), 4.95 
(d, J = 7.4, 1H), 4.37 – 4.16 (m, 2H), 4.12 – 3.79 (m, 4H), 3.47 (s, 3H), 1.71 – 1.37 (m, 5H). 
 
 
Synthesis of napthoyl 2-ester compound 31b 
The pure product was purified by flash chromatography using Hexane: EtOAc with a yield of 
36%.   1H NMR (400 MHz, CDCl3) δ 8.90 (d, J = 8.3, 1H), 8.68 (d, J = 9.1, 1H), 8.29 (d, J = 7.3, 
1H), 7.91 (tdd, J = 18.3, 15.0, 7.9, 5H), 7.58 – 7.33 (m, 7H), 6.05 (t, J = 9.5, 1H), 5.35 (dd, J = 
10.0, 3.7, 1H), 5.23 (d, J = 3.7, 1H), 4.34 – 4.14 (m, 2H), 4.09 – 3.79 (m, 4H), 3.43 (d, J = 25.9, 
3H), 1.72 – 1.36 (m, 5H).  
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Synthesis of heptanoyl dimer compound 32a 
The pure product was purified by flash chromatography using Hexane:EtOAc with a yield of 
22%. 1H NMR (400 MHz, CDCl3) δ 4.92 (d, J = 3.7, 1H), 4.75 (dd, J = 9.7, 3.8, 1H), 4.02 (td, J 
= 9.3, 2.8, 1H), 3.88 (dd, J = 10.5, 5.0, 1H), 3.77 (t, J = 10.3, 1H), 3.72 – 3.55 (m, 2H), 3.36 (s, 
3H), 2.40 (t, J = 7.5, 2H), 2.27 (d, J = 2.8, 1H), 1.73 – 1.60 (m, 1H), 1.58 – 1.22 (m, 21H). ) 13C 
NMR (100 MHz, CDCl3) δ 173.8, 101.1, 99.4, 81.9, 72.3, 68.3, 64.5, 63.5, 53.9, 36.6, 30.9, 28.9, 
25.6, 21.7, 14.6. 
 
Synthesis of heptanoyl 2-ester compound 32b 
The pure product was purified by flash chromatography using Hexane:EtOAc,  product yield was 
15%.  1H NMR (400 MHz, CDCl3) δ 5.42 (t, J = 9.5, 1H), 4.96 – 4.81 (m, 1H), 4.75 (dd, J = 9.7, 
3.8, 1H), 4.02 (td, J = 9.3, 2.8, 1H), 3.88 (dd, J = 10.4, 5.0, 1H), 3.83 – 3.70 (m, 1H), 3.70 – 3.54 
(m, 2H), 3.37 (d, J = 3.2, 3H), 2.44 – 2.36 (m, 2H), 1.72 – 1.58 (m, 2H), 1.58 – 0.81 (m, 24H) 
13C NMR (100 MHz, CDCl3) δ 174.9, 102.1, 99.0, 82.3, 71.0, 69.0, 65.5, 62.5, 54.2, 36.9, 31.7, 
29.0, 25.8, 22.7, 14.2 
 
Synthesis of benzylidene benzyl amine compound 35 
The compound was purified by flash chromatography using Hexane:DCM: MeOH, the pure 
product was obtained in 91% yield. 1H NMR (400 MHz, DMSO) δ 7.73 (t, J = 11.0, 1H), 7.43 (d, 
J = 4.8, 3H), 7.39 – 7.33 (m, 5H), 7.33 – 7.15 (m, 11H), 5.59 (d, J = 10.6, 1H), 5.25 (t, J = 8.0, 
1H), 4.64 (t, J = 6.3, 1H), 4.16 (dt, J = 11.4, 5.8, 1H), 3.87 (td, J = 9.8, 3.6, 1H), 3.78 – 3.47 (m, 
12H), 3.09 (dd, J = 26.9, 16.2, 8H), 2.44 (dd, J = 34.0, 4.5, 14H). 13C NMR (100 MHz, DMSO) δ 
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171.9, 140.7, 138.4, 129.6, 128.9, 128.8, 101.6, 99.4, 82.4, 68.7, 68.7, 63.3, 55.3, 53.9, 52.5, 52.0, 
40.6, 40.4  
 
Synthesis of pyridinium acetamide compound 36 
The compound was purified by flash chromatography using Hexane:DCM: MeOH, the pure 
product was obtained in 89% yield.  1H NMR (CDCl3, 400MHz) δ (ppm) 8.83(dd, J = 1.5, 5.5 
Hz, 2H), 8.49 (td, J = 1.5, 8.1 Hz, 1H), 8.02 (dd, J = 6.6, 7.7 Hz, 2H),7.45-7.41 (m, 2H), 7.30-
7.25 (m, 3H), 5.56 (s, 1H), 4.71 (m, 1H), 4.23-4.18 (m, 1H), 4.09 (dd, J = 3.7, 10.3 Hz, 1H), 3.92 
(pt, J = 9.5, 9.9 Hz, 1H), 3.82-3.72 (m, 3H), 3.62 (t, J =9.2 Hz, 1H), 3.43 (s, 3H). 13C NMR 
(CDCl3, 100MHz) δ 166.4, 147.8, 146.8, 138.0, 129.8, 128.7, 128.7, 128.4, 128.1, 126.8, 103.3, 
100.4, 81.9, 70.6, 69.2, 64.3, 56.3 
 
Synthesis of imidazole derivative with isopropylidene head group 37 
 The compound was purified by flash chromatography using Hexane:DCM:MeOH, the pure 
product was obtained in 89% yield. 1H NMR (400 MHz, DMSO) δ 8.30 (t, J = 14.5, 1H), 7.60 (s, 
1H), 7.40 (dd, J = 29.7, 4.3, 6H), 6.82 (d, J = 41.6, 1H), 4.69 (s, 2H), 4.63 (d, J = 3.4, 1H), 4.16 
(dd, J = 9.9, 4.6, 1H), 3.83 (dt, J = 27.3, 9.7, 2H), 3.77 (s, 6H), 3.32 (d, J = 18.0, 21H), 3.06 (dd, 
J = 14.5, 7.2, 2H), 2.48 (s, 7H). ). 13C NMR (100MHz, DMSO) δ 170.1, 140.3, 130.5, 128.7, 
128.5, 127.4, 103.0, 100.1, 82.7, 70.1, 69.7, 63.8, 37.9 
 
Synthesis of Head group compound 40 
The crude product was purified by flash chromatography using Hexane:DCM:MeOH. The pure 
potion of the compound isolated was 84%. 1H NMR (400 MHz, CDCl3) δ 5.27 (d, J = 24.2, 1H), 
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4.64 (d, J = 3.6, 1H), 3.86 (dd, J = 10.5, 5.2, 1H), 3.75 (t, J = 10.4, 1H), 3.67 – 3.47 (m, 4H), 
3.42 – 3.34 (m, 4H), 2.74 (dd, J = 9.3, 3.7, 1H), 1.60 – 1.39 (m, 10H). 13C NMR (100 MHz, 
CDCl3) δ 173.2, 102.1, 101.5, 82.2, 72.1, 69.3, 62.8, 56.9, 55.7, 26.4, 23.3 
 
Synthesis of Head group compound 41 
Crude product was purified by flash chromatography using Hexane:DCM;MeOH. The pure 
product was obtained with the yield of 71%. 1H NMR (400 MHz, CDCl3) δ 4.64 (d, J = 3.7, 1H), 
3.85 (dt, J = 8.0, 4.0, 1H), 3.78 (s, 2H), 3.75 (s, 1H), 3.73 (s, 1H), 3.67 – 3.45 (m, 4H), 3.40 – 
3.33 (m, 4H), 2.73 (dt, J = 9.2, 4.6, 1H), 1.43 (dd, J = 34.8, 19.2, 10H). 13C NMR (100 MHz, 
CDCl3) δ 100.1, 98.8, 74.8, 70.9, 63.1, 62.4, 56.9, 54.9, 29.2 
 
Synthesis of isopropylidine head group compound 42 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH,  pure 
portion of  isolated product was 87%. 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.6, 2H), 6.88 
(d, J = 8.7, 2H), 5.49 (s, 1H), 4.67 (d, J = 3.6, 1H), 4.25 (dd, J = 9.5, 4.2, 1H), 3.83 – 3.66 (m, 
7H), 3.49 – 3.36 (m, 4H), 2.77 (dd, J = 9.6, 3.6, 1H). 13C NMR (100 MHz, CDCl3) δ 172.8, 102.1, 
101.5, 82.2, 72.1, 69.3, 62.8, 56.9, 55.6, 55.5, 20.5  
 
Synthesis of isopropropylidine imidazole derivative 43 
The compound was purified by flash chromatography using Hexane:DCM:MeOH, pure portion 
of isolated product yield was 91%.  1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 9.1, 1H), 7.66 – 
7.30 (m, 7H), 5.27 (d, J = 12.6, 1H), 4.67 (d, J = 3.8, 1H), 4.12 (td, J = 9.5, 3.8, 1H), 3.89 – 3.85 
(m, 1H), 3.76 (td, J = 12.9, 5.1, 5H), 3.67 – 3.57 (m, 2H), 3.46 – 3.30 (m, 5H), 3.29 (s, 1H), 3.24 
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(s, 1H), 1.47 (d, J = 10.8, 4H), 1.45 (s, 4H). 13C NMR (100 MHz, CDCl3) δ 173.1, 139.6, 128.8, 
124.6, 100.0, 99.2, 80.9, 74.4, 63.5, 62.5, 55.4, 45.5, 55.2, 19.3 
 
Synthesis of benzyl amine derivative of isopropylidene head group compound 44 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH, the pure 
product was obtained as a white powder in 86% yield. 1H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 
9.1, 1H), 7.37 – 7.20 (m, 7H), 5.26 (d, J = 12.6, 1H), 4.63 (d, J = 3.8, 1H), 4.12 (td, J = 9.5, 3.8, 
1H), 3.88 – 3.82 (m, 1H), 3.74 (td, J = 12.9, 5.1, 5H), 3.65 – 3.57 (m, 2H), 3.46 – 3.30 (m, 5H), 
3.27 (s, 1H), 3.23 (s, 1H), 1.49 (d, J = 10.8, 4H), 1.45 (s, 4H). 13C NMR (100 MHz, CDCl3) δ 
173.1, 155.4, 139.5, 128.8, 128.4, 127.6, 100.1, 99.2, 74.9, 71.1, 63.5, 62.5, 55.4, 53.5, 51.9, 29.3, 
19.3 
 
Synthesis of pyridine derivative of isopropylidene head group compound 45  
The crude of the product was dried and product was obtained as a white powder with the yield of 
91%. 1H NMR (400 MHz, CDCl3) δ 8.94 (d, J = 6.3, 2H), 8.42 (t, J = 7.3, 1H), 7.96 (t, J = 6.8, 
3H), 5.67 (d, J = 15.8, 1H), 5.52 (d, J = 15.8, 1H), 4.61 (d, J = 3.5, 1H), 3.97 (dd, J = 10.0, 3.6, 
1H), 3.73 (ddd, J = 26.5, 13.4, 7.1, 5H), 3.63 – 3.38 (m, 17H), 3.37 – 3.21 (m, 8H), 1.43 (s, 5H), 
1.31 (d, J = 28.4, 5H). 13C NMR (100 MHz, CDCl3) δ 164.6, 146.4, 145.9, 127.8, 100.1, 98.9, 
74.3, 69.5, 63.6, 62.4, 62.3, 55.9, 55.5, 55.2, 29.0, 19.0 
 
Synthesis of compound 47   
About 10 gm of p-anisaldehyde was dissolved in 30mL of methanol in 250 mL of round bottom 
flask (RBF). 1.2 equivalents of triethyl orthoformate were added into the reaction flask. Catalytic 
 
 
34 
amount of PTSA was added into RBF. Reflux the reaction at 75o C for 8 hrs. Neutralize the 
reaction with 2 equivalents of sodium methoxide and filtered it. Resulting liquid was 
concentrated and dried it. Product was yellowish color liquid with 89% yield. 
 
Synthesis of head group 49  
5.00g of N-Acetyl-D-glucosamine was dissolved in 50 mL of methanol. The reaction mixture 
was refluxed with Amberlite IR-120 resin (5.00 g) over night. Resin was filtered by methanol, 
which was removed by drying in high vacuum pump to yield 4.9 g (90%) α and β mixtures of 
anomers (~8:1). α/β mixtures of methyl group at the anomeric position was dissolved in 25mL of 
DMF, 9.5 mL of p-methoxy dimethyl benzylidene acetal, and 0.3g of p-toluenesulfonic acid at 
60°C for 2hrs. DMF was removed in vacuum to yield a 5.5g (84%) white solid (mixture of α 
and β anomers). The α anomer was purified by column, which was then dissolved in 75 mL of 
refluxing 3N KOH ethanol for 18 hours. Reaction was diluted with a 2% MeOH in DCM (~150 
mL) and water (2x100 mL). After drying the DCM layer over anhydrous sodium sulphate, crude 
was purified by column chromatography using 2% MeOH in DCM product yield was 71%.  
 
General procedure for the synthesis of amide 
To a 50 mL of round bottom flask 50 mg of head group was dissolved in 2 mL of THF or DCM 
and 2 equivalent of potassium carbonate or pyridine was added into the reaction flask. Cooled 
the reaction mixture at 00 C and 1 equivalent of the corresponding acid chloride were added drop 
wise to the solution. The mixture was left stirring for 6-10 hrs, after which the mixture was 
concentrated under nitrogen. The crude residue was purified by flash chromatography using 
hexane/DCM/MeOH. The resulting purified compound was tested for their gelation activity. 
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Synthesis of hexyl amide compound 50 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH, the pure 
product was obtained in 87% yield. 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.7, 2H), 6.85 (d, 
J = 8.8, 2H), 5.83 (d, J = 8.5, 1H), 5.49 (s, 1H), 4.69 (d, J = 3.8, 1H), 4.26 – 4.16 (m, 2H), 3.86 
(td, J = 9.6, 3.2, 1H), 3.77 (d, J = 1.1, 4H), 3.76 – 3.71 (m, 2H), 3.57 – 3.51 (m, 1H), 3.37 (t, J = 
5.3, 4H), 3.13 (d, J = 3.3, 1H), 2.22 (t, J = 7.7, 2H), 1.68 – 1.58 (m, 3H), 1.35 – 1.22 (m, 5H), 
0.87 (dd, J = 7.0, 6.0, 4H). 13C NMR (100 MHz, CDCl3) δ 174.9, 160.4, 129.9, 127.9, 113.8, 
102.1, 82.3, 71.1, 69.0, 62.5, 55.5, 55.4, 54.2, 36.8, 31.5, 25.5, 22.6 
 
Synthesis of heptyl amide compound 51 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH, the pure 
product was obtained in 88% yield. 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.39 (m, 2H), 6.91 – 
6.85 (m, 2H), 5.82 (d, J = 8.7, 1H), 5.53 (s, 1H), 4.71 (d, J = 3.9, 1H), 4.29 – 4.19 (m, 2H), 3.89 
(td, J = 9.6, 3.2, 1H), 3.82 – 3.74 (m, 6H), 3.61 – 3.54 (m, 1H), 3.43 – 3.37 (m, 4H), 3.06 (d, J = 
3.3, 1H), 2.29 – 2.22 (m, 2H), 1.64 (dd, J = 15.2, 7.6, 2H), 1.32 (dd, J = 15.7, 5.7, 8H), 0.88 (t, J 
= 6.9, 4H). 13C NMR (100 MHz, CDCl3) δ 174.9, 160.4, 129.9, 127.9, 115.6, 113.8, 102.1, 99.0, 
82.3, 71.0, 69.0, 62.6, 55.5, 54.2, 36.9, 31.7, 29.0, 25.7, 22.7, 14.2 
 
Synthesis of octyl amide compound 52  
The crude product was purified by flash chromatography using Hexane: DCM, the pure product 
was obtained in 82% yield. 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.6, 2H), 6.84 (t, J = 12.3, 
2H), 5.88 (t, J = 12.0, 1H), 5.47 (d, J = 14.9, 1H), 4.69 (t, J = 7.5, 1H), 4.31 – 4.14 (m, 2H), 3.85 
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(dd, J = 19.4, 9.6, 1H), 3.81 (s, 4H), 3.76 – 3.68 (m, 2H), 3.61 – 3.48 (m, 1H), 3.36 (d, J = 15.9, 
4H), 2.31 – 2.14 (m, 2H), 1.71 – 1.54 (m, 2H), 1.38 – 1.15 (m, 9H), 0.96 – 0.79 (m, 3H). 13C 
NMR (100 MHz, CDCl3) δ 172.5, 158.0, 127.5, 125.5, 111.4, 99.7, 96.6, 79.8, 68.4, 66.6, 60.2, 
53.1, 51.8, 34.4, 29.5, 27.8, 26.9, 26.8, 21.2, 11.9 
 
Synthesis of benzyl amide compound 53 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH, the pure 
product was obtained in 87% yield. 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 7.6, 2H), 7.52 (t, 
J = 7.4, 1H), 7.43 (dd, J = 12.4, 5.5, 4H), 7.26 (s, 1H), 6.88 (d, J = 8.8, 2H), 6.53 (d, J = 8.6, 1H), 
5.53 (s, 1H), 4.83 (d, J = 3.8, 1H), 4.47 – 4.40 (m, 1H), 4.28 (dd, J = 9.0, 3.6, 1H), 4.01 (td, J = 
9.7, 3.2, 1H), 3.86 – 3.74 (m, 6H), 3.62 (t, J = 9.0, 1H), 3.43 (s, 3H), 3.19 (d, J = 3.3, 1H) 13C 
NMR (100 MHz, CDCl3) δ 168.7, 160.5, 132.2, 129.7, 128.9, 127.9, 127.4, 113.9, 102.1, 99.1, 
82.2, 70.9, 69.0, 62.6, 55.6, 55.5, 54.7 
 
Synthesis of 5-hexynoyl amide compound 55 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH,  the pure 
product was obtained in 87% yield. 1H NMR (400 MHz, CDCl3) δ 7.41 (d, J = 8.4, 2H), 6.88 (d, 
J = 8.5, 2H), 5.90 (d, J = 8.7, 1H), 5.52 (s, 1H), 4.71 (d, J = 3.7, 1H), 4.30 – 4.19 (m, 2H), 3.89 
(td, J = 9.5, 2.8, 1H), 3.83 – 3.71 (m, 6H), 3.56 (t, J = 9.0, 1H), 3.38 (d, J = 23.2, 4H), 2.99 (d, J 
= 3.1, 1H), 2.40 (t, J = 7.3, 2H), 2.28 (dd, J = 8.0, 5.1, 2H), 1.99 (s, 1H), 1.88 (dt, J = 13.2, 6.7, 
2H). 13C NMR (100 MHz, CDCl3) δ 173.8, 160.5, 129.8, 127.9, 113.9, 102.1, 99.0, 82.2, 75.8, 
71.1, 69.6, 69.0, 62.6, 55.5, 55.5, 54.2, 35.2, 24.1, 17.8 
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Synthesis of pyridine amide 57 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH ,  the pure 
product was obtained in 90% yield. 1H NMR (400 MHz, CDCl3) δ 8.80 (d, J = 5.8, 2H), 8.33 (dd, 
J = 15.2, 8.0, 2H), 7.88 (t, J = 7.0, 2H), 7.27 (d, J = 4.8, 1H), 6.72 (d, J = 8.6, 2H), 5.53 (d, J = 
15.9, 1H), 5.41 (d, J = 15.9, 1H), 5.37 (s, 1H), 4.58 (d, J = 3.4, 1H), 4.10 (dd, J = 9.9, 4.5, 1H), 
4.00 – 3.82 (m, 13H), 3.75 – 3.56 (m, 7H), 3.42 (t, J = 9.2, 1H), 3.29 (s, 4H), 3.20 (s, 1H). 13C 
NMR (100 MHz, CDCl3) δ 164.6, 160.3, 146.3, 145.9, 129.8, 127.8, 127.7, 115.6, 113.6, 101.9, 
98.6, 98.4, 81.7, 68.9, 62.7, 62.4, 55.4, 55.3, 55.0 
 
Synthesis of benzyl amide derivative 58 
The crude product was purified by flash chromatography using Hexane: DCM: MeOH, the pure 
product was obtained in 87% yield. 1H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 9.1, 1H), 7.42 (d, 
J = 8.7, 2H), 7.37 – 7.24 (m, 6H), 6.87 (d, J = 8.6, 2H), 5.51 (s, 1H), 4.68 (d, J = 3.8, 1H), 4.26 
(dd, J = 9.2, 3.8, 1H), 4.18 (td, J = 9.6, 3.8, 1H), 3.90 (t, J = 9.6, 1H), 3.84 – 3.75 (m, 5H), 3.75 – 
3.68 (m, 3H), 3.56 (t, J = 9.0, 1H), 3.43 – 3.35 (m, 4H), 3.29 (s, 1H), 3.24 (d, J = 3.7, 1H). 13C 
NMR (100 MHz, CDCl3) δ 173.2, 160.4, 139.5, 129.9, 128.8, 128.4, 127.9, 127.7, 113.9, 102.1, 
99.2, 82.2, 70.8, 69.1, 62.6, 55.9, 55.5, 54.0, 53.9, 51.9 
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